Wockhardt Share Price Surges 19% After US FDA Accepts New Drug Application
On Monday, Wockhardt shares soared more than 19% to hit ₹1,473 after the US FDA officially accepted the New Drug Application for its antibiotic Zaynich, marking a significant regulatory achievement.This sudden spike drew market attention, especially after Wockhardt shares had been under pressure ...
Easy & quick